Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway*
暂无分享,去创建一个
R. Halaban | E. Cheng | D. Hebert | E. Trombetta | M. Wahl | S. Ariyan | S. Svedine | Robin S Patton | Sherri Svedine | Robin S. Patton
[1] K. Wakamatsu,et al. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. , 2001, Experimental cell research.
[2] R. Burd,et al. Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors. , 2001, Cancer research.
[3] M. Hoogduijn,et al. Melanosomal pH, pink locus protein and their roles in melanogenesis. , 2001, The Journal of investigative dermatology.
[4] Takashi Saito,et al. The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum , 2001, The EMBO journal.
[5] R. Spritz,et al. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. , 2001, The Biochemical journal.
[6] R. Halaban,et al. Proper Folding and Endoplasmic Reticulum to Golgi Transport of Tyrosinase Are Induced by Its Substrates, DOPA and Tyrosine* , 2001, The Journal of Biological Chemistry.
[7] M. Brilliant. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. , 2001, Pigment cell research.
[8] T. Eisenhaure,et al. Translation Rate of Human Tyrosinase Determines ItsN-Linked Glycosylation Level* , 2001, The Journal of Biological Chemistry.
[9] G. Raposo,et al. Distinct Protein Sorting and Localization to Premelanosomes, Melanosomes, and Lysosomes in Pigmented Melanocytic Cells✪ , 2001, The Journal of cell biology.
[10] B. Fuller,et al. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. , 2001, Experimental cell research.
[11] M. Brilliant,et al. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. , 2000, The Journal of investigative dermatology.
[12] P. Briand,et al. Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line , 2000, Journal of cellular physiology.
[13] R. Halaban,et al. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Marks,et al. A Common Temperature-sensitive Allelic Form of Human Tyrosinase Is Retained in the Endoplasmic Reticulum at the Nonpermissive Temperature* , 2000, The Journal of Biological Chemistry.
[15] R. Halaban,et al. Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells , 2000, The Journal of experimental medicine.
[16] R. Tsien,et al. Organelle pH studies using targeted avidin and fluorescein-biotin. , 2000, Chemistry & biology.
[17] J R Griffiths,et al. Causes and consequences of tumour acidity and implications for treatment. , 2000, Molecular medicine today.
[18] R. Tsien,et al. Studying organelle physiology with fusion protein-targeted avidin and fluorescent biotin conjugates. , 2000, Methods in enzymology.
[19] A Helenius,et al. Setting the standards: quality control in the secretory pathway. , 1999, Science.
[20] Riley Pa. The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis. , 1999 .
[21] M Forgac,et al. Structure and Properties of the Vacuolar (H+)-ATPases* , 1999, The Journal of Biological Chemistry.
[22] R. Gillies,et al. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. , 1999, Biochemical pharmacology.
[23] N. Nelson,et al. Vacuolar and plasma membrane proton-adenosinetriphosphatases. , 1999, Physiological reviews.
[24] M. Brilliant,et al. The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye. , 1999, Experimental eye research.
[25] Simon,et al. Role of organelle pH in tumor cell biology and drug resistance. , 1999, Drug discovery today.
[26] K. Väänänen,et al. Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1. , 1998, Molecular biology of the cell.
[27] D. Bennett,et al. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes. , 1998, Experimental cell research.
[28] P. Riley,et al. Tyrosinase autoactivation and the problem of the lag period. , 1998, Pigment cell research.
[29] I. Tannock,et al. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.
[30] S. Simon,et al. Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy , 1998, The Journal of experimental medicine.
[31] G. Hör,et al. Primary staging and follow‐up of high risk melanoma patients with whole‐body 18F‐fluorodeoxyglucose positron emission tomography , 1998, Cancer.
[32] S. Grinstein,et al. Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Shabanowitz,et al. The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol , 1998, The Journal of experimental medicine.
[34] MH Brilliant,et al. Mutations of the human P gene associated with type II oculocutaneous albinism (OCA2) , 1998 .
[35] F. Marincola,et al. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. , 1998, Journal of immunotherapy.
[36] J. Nordlund. The pigmentary system : physiology and pathophysiology , 1998 .
[37] D. Leeper,et al. Altered proton extrusion in cells adapted to growth at low extracellular pH , 1997, Journal of cellular physiology.
[38] C. A. Ramsden,et al. Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.
[39] C. Dang,et al. Oncogenes in Tumor Metabolism, Tumorigenesis, and Apoptosis , 1997, Journal of bioenergetics and biomembranes.
[40] M. Finbow,et al. The vacuolar H+-ATPase: a universal proton pump of eukaryotes. , 1997, The Biochemical journal.
[41] R. Halaban,et al. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Stevens,et al. Structure, function and regulation of the vacuolar (H+)-ATPase. , 1997, Annual review of cell and developmental biology.
[43] K. Altendorf,et al. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. , 1997, The Journal of experimental biology.
[44] A Sette,et al. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes , 1996, The Journal of experimental medicine.
[45] S. Simon,et al. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). , 1996, Biochemistry.
[46] H. Ploegh,et al. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment , 1995, The Journal of cell biology.
[47] D. Schadendorf,et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. , 1995, The American journal of pathology.
[48] W. K. Schmidt,et al. Ionic milieu controls the compartment-specific activation of pro-opiomelanocortin processing in AtT-20 cells. , 1995, Molecular biology of the cell.
[49] Yao-Tseng Chen,et al. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] A. Houghton,et al. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75 , 1995, The Journal of cell biology.
[51] K. Sakaguchi,et al. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. , 1995, Journal of immunology.
[52] D. Leeper,et al. Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[53] M. Brilliant,et al. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[54] W. Berger,et al. Intrinsic MDR‐1 gene and P‐glycoprotein expression in human melanoma cell lines , 1994, International journal of cancer.
[55] A. Helenius,et al. Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus , 1994, The Journal of cell biology.
[56] R. Spritz,et al. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. , 1994, The New England journal of medicine.
[57] S. Simon,et al. Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[58] R. Gillies,et al. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.
[59] I. Roninson,et al. MDR-1 expression in metastatic malignant melanoma. , 1993, The Journal of surgical research.
[60] R. Spritz,et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism , 1993, Nature.
[61] M. Gerretsen,et al. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.
[62] R. Gillies,et al. A Plasma Membrane V‐type H+‐ATPase May Contribute to Elevated Intracellular pH (pHin) in Some Human Tumor Cells a , 1992, Annals of the New York Academy of Sciences.
[63] M. Lyon,et al. The Mouse Pink-Eyed Dilution Gene: Association with Human Prader-Willi and Angelman Syndromes , 1992, Science.
[64] M. Brilliant,et al. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. , 1991, Science.
[65] P. Natali,et al. Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope. , 1991, The Journal of investigative dermatology.
[66] R. Gillies,et al. Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[67] B. Kwon,et al. Tyrosinases of murine melanocytes with mutations at the albino locus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[68] I Mellman,et al. Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.
[69] James J. Nordlund,et al. THE PIGMENTARY SYSTEM , 1985 .
[70] E. Racker. The Warburg effect: two years later. , 1983, Science.
[71] A. Tartakoff. Perturbation of vesicular traffic with the carboxylic ionophore monensin , 1983, Cell.
[72] F. Maxfield. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts , 1982, The Journal of cell biology.
[73] H. Lodish,et al. Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus , 1980, Cell.
[74] A. Tartakoff,et al. Plasma cell immunoglobulin secretion. Arrest is accompanied by alterations the golgi complex , 1977, The Journal of experimental medicine.
[75] R. Halaban,et al. Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. , 1977, Experimental cell research.
[76] S. Pomerantz. A sensitive new assay for the oxidation of 3,4-dihydroxy L-phenylalanine by tyrosinase. , 1976, Analytical biochemistry.
[77] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[78] T. Fitzpatrick,et al. Mammalian tyrosinase; preparation and properties. , 1949, The Journal of biological chemistry.
[79] H. Raper. THE AEROBIC OXIDASES , 1928 .